BlackRock Health Sciences Term Trust Announces Monthly Dividend of $0.09 (NYSE:BMEZ)

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Monday, April 1st, Zacks reports. Shareholders of record on Monday, April 15th will be paid a dividend of 0.09 per share on Tuesday, April 30th. This represents a $1.08 dividend on an annualized basis and a yield of 6.96%. The ex-dividend date of this dividend is Friday, April 12th.

BlackRock Health Sciences Term Trust has increased its dividend payment by an average of 16.5% per year over the last three years.

BlackRock Health Sciences Term Trust Stock Down 1.4 %

NYSE BMEZ opened at 15.51 on Thursday. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.95. The business’s 50-day simple moving average is 16.09 and its 200-day simple moving average is 14.90.

Insider Buying and Selling

In related news, major shareholder Saba Capital Management, L.P. purchased 46,421 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Monday, April 1st. The shares were purchased at an average cost of 16.33 per share, with a total value of 758,054.93. Following the transaction, the insider now owns 20,538,431 shares of the company’s stock, valued at approximately 335,392,578.23. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last ninety days, insiders have purchased 2,171,278 shares of company stock valued at $34,079,779.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Hedge funds and other institutional investors have recently bought and sold shares of the business. Raymond James Financial Services Advisors Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 15.8% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 69,130 shares of the company’s stock valued at $1,387,000 after acquiring an additional 9,413 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its position in BlackRock Health Sciences Term Trust by 37.5% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 23,480 shares of the company’s stock valued at $471,000 after purchasing an additional 6,407 shares during the period. First Trust Advisors LP boosted its position in BlackRock Health Sciences Term Trust by 8.3% during the 1st quarter. First Trust Advisors LP now owns 86,674 shares of the company’s stock valued at $1,739,000 after purchasing an additional 6,654 shares during the period. Quantedge Capital Pte Ltd boosted its position in BlackRock Health Sciences Term Trust by 448.0% during the 1st quarter. Quantedge Capital Pte Ltd now owns 69,600 shares of the company’s stock valued at $1,396,000 after purchasing an additional 56,900 shares during the period. Finally, City of London Investment Management Co. Ltd. raised its position in shares of BlackRock Health Sciences Term Trust by 45.6% during the first quarter. City of London Investment Management Co. Ltd. now owns 218,424 shares of the company’s stock worth $4,376,000 after purchasing an additional 68,452 shares during the period.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.